{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    8,
    125
  ],
  "modelUsed": "claude-opus-4-5",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "a",
        "scope": {
          "code": "Global",
          "codeSystem": "USDM",
          "decode": "Global"
        },
        "instanceType": "StudyAmendment",
        "summary": "The GPHK clinical protocol has been amended to extend the safety follow-up period in order to better characterize the glycemic status of study participants.",
        "effectiveDate": "2020-07-24",
        "reasonIds": [
          "ar_1_1",
          "ar_1_2"
        ],
        "previousVersion": "Original Protocol",
        "newVersion": "a"
      },
      {
        "id": "amend_2",
        "number": "b",
        "scope": {
          "code": "Global",
          "codeSystem": "USDM",
          "decode": "Global"
        },
        "instanceType": "StudyAmendment",
        "summary": "The overall rationale for the current GPHK protocol amendment is to update the key study objectives and endpoints in Section 3; clarify the definition of incident diabetes, add guidance for retesting, confirmation, recording, and adjudication of incident diabetes in Section 4.1.2.3; add guidance in Sections 6.6.1 and 6.6.3 for study drug dose modification during the additional 2-year treatment period in participants with perceived excessive weight loss; and to update information relevant to statistical analyses in Section 9 to align with recent updates to the SAP.",
        "effectiveDate": "2021-10-04",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2",
          "ar_2_3"
        ],
        "previousVersion": "a",
        "newVersion": "b"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_1_2",
        "code": "SAFETY",
        "description": "Safety",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_3",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "United States",
        "instanceType": "Country",
        "code": "US"
      }
    ],
    "studySites": [],
    "summary": {
      "amendmentCount": 2,
      "countryCount": 1,
      "siteCount": 0
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "Global",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "a",
        "effectiveDate": "2020-07-24",
        "summary": "The GPHK clinical protocol has been amended to extend the safety follow-up period in order to better characterize the glycemic status of study participants.",
        "previousVersion": "Original Protocol",
        "newVersion": "a",
        "reasons": [
          "Regulatory",
          "Safety"
        ]
      },
      {
        "number": "b",
        "effectiveDate": "2021-10-04",
        "summary": "The overall rationale for the current GPHK protocol amendment is to update the key study objectives and endpoints in Section 3; clarify the definition of incident diabetes, add guidance for retesting, confirmation, recording, and adjudication of incident diabetes in Section 4.1.2.3; add guidance in Sections 6.6.1 and 6.6.3 for study drug dose modification during the additional 2-year treatment period in participants with perceived excessive weight loss; and to update information relevant to statistical analyses in Section 9 to align with recent updates to the SAP.",
        "previousVersion": "a",
        "newVersion": "b",
        "reasons": [
          "Scientific",
          "Operational",
          "Administrative"
        ]
      }
    ],
    "geographicScope": {
      "type": "Global",
      "countries": [
        {
          "name": "United States",
          "code": "US"
        }
      ],
      "regions": [],
      "plannedSites": null
    },
    "sites": []
  }
}